Recurrent American Cutaneous Leishmaniasis
Overview
Authors
Affiliations
Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis.
Lafleur A, Daffis S, Mowbray C, Arana B Vaccines (Basel). 2024; 12(10).
PMID: 39460345 PMC: 11511131. DOI: 10.3390/vaccines12101179.
de Almeida Santos G, Sousa J, Aguiar A, Torres K, Coelho A, Ferreira A Trop Med Infect Dis. 2023; 8(9).
PMID: 37755891 PMC: 10534360. DOI: 10.3390/tropicalmed8090430.
Cutaneous Leishmaniasis: A 2022 Updated Narrative Review into Diagnosis and Management Developments.
de Vries H, Schallig H Am J Clin Dermatol. 2022; 23(6):823-840.
PMID: 36103050 PMC: 9472198. DOI: 10.1007/s40257-022-00726-8.
Mucocutaneous Leishmaniasis in a Pregnant Immigrant.
Briggs N, Wei B, Ahuja C, Baker C, Foppiano Palacios C, Lee E Open Forum Infect Dis. 2022; 9(8):ofac360.
PMID: 35928503 PMC: 9345408. DOI: 10.1093/ofid/ofac360.
Volpedo G, Pacheco-Fernandez T, Holcomb E, Cipriano N, Cox B, Satoskar A Front Cell Infect Microbiol. 2021; 11:685296.
PMID: 34169006 PMC: 8217655. DOI: 10.3389/fcimb.2021.685296.